share_log

一品红(300723.SZ):全资子公司一类创新药APH01727片获得临床试验批准

Apichope Pharmaceutical (300723.SZ) announced that its wholly-owned subsidiary's innovative drug APH01727 tablet has obtained approval for clinical trials.

Gelonghui Finance ·  Jul 23 23:51

Apichope pharmaceutical (300723.SZ) announced on July 24 that the drug clinical trial application for the innovative drug, APH01727 tablets, which was independently developed by its wholly-owned subsidiary, Guangzhou Apichope Pharmaceutical Co., Ltd., has been approved by the National Medical Products Administration and received the Approval of Drug Clinical Trial. The clinical trial will be conducted soon.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment